The Intrinsic Contributions of Tyrosine, Serine, Glycine and Arginine to the Affinity and Specificity of Antibodies
|
journal
|
April 2008 |
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen
|
journal
|
February 2013 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
|
journal
|
March 2016 |
Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys
|
journal
|
June 2011 |
Safety and Immunogenicity of a Meningococcal B Bivalent rLP2086 Vaccine in Healthy Toddlers Aged 18–36 Months
|
journal
|
October 2012 |
Computational characterization of B-cell epitopes
|
journal
|
July 2008 |
Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain
|
journal
|
October 1999 |
Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity
|
journal
|
June 2016 |
Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of Protection
|
journal
|
March 2001 |
Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions
|
journal
|
November 2004 |
Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
|
journal
|
August 2014 |
Antibody Recognition of Disordered Antigens
|
journal
|
January 2016 |
BIGSdb: Scalable analysis of bacterial genome variation at the population level
|
journal
|
December 2010 |
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined
|
journal
|
February 2016 |
Three-Dimensional Structures of the Free and Antigen-Bound Fab from Monoclonal Antilysozyme Antibody HyHEL-63 † , ‡
|
journal
|
May 2000 |
Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding
|
journal
|
September 2016 |
Antigen–antibody interface properties: Composition, residue interactions, and features of 53 non-redundant structures
|
journal
|
March 2012 |
XDS
|
journal
|
January 2010 |
Inference of Macromolecular Assemblies from Crystalline State
|
journal
|
September 2007 |
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
|
journal
|
May 2009 |
How antibodies use complement to regulate antibody responses
|
journal
|
October 2014 |
Crystal Structure of an Anti-meningococcal Subtype P1.4 PorA Antibody Provides Basis for Peptide–Vaccine Design
|
journal
|
September 2005 |
A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups
|
journal
|
May 2009 |
Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086)
|
journal
|
April 2011 |
Epitope Mapping of a Bactericidal Monoclonal Antibody against the Factor H Binding Protein of Neisseria meningitidis
|
journal
|
February 2009 |
Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response
|
journal
|
February 2013 |
Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein
|
journal
|
April 2004 |
Bactericidal antibody recognition of a PorA epitope ofNeisseria meningitidis: Crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide
|
journal
|
September 1997 |
Two cross‐reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties
|
journal
|
December 2013 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
How good are my data and what is the resolution?
|
journal
|
June 2013 |
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire
|
journal
|
November 2016 |
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
|
journal
|
April 2014 |
Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine
|
journal
|
February 2015 |
Environmental dissemination of pathogenic Listeria monocytogenes in flowing surface waters in Switzerland
|
journal
|
April 2021 |
The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance
|
journal
|
June 2006 |
Structural evidence for induced fit as a mechanism for antibody-antigen recognition
|
journal
|
February 1992 |
Getting oriented with antibodies
|
journal
|
February 2017 |
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults
|
journal
|
March 2013 |
Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
|
journal
|
December 2008 |
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
|
journal
|
February 2009 |
Neisseria meningitidis factor H-binding protein bound to monoclonal antibody JAR5: implications for antibody synergy
|
journal
|
December 2016 |
Effects of pH and Low Density Lipoprotein (LDL) on PCSK9-dependent LDL Receptor Regulation
|
journal
|
May 2007 |
Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
|
journal
|
November 2010 |
A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
|
journal
|
March 2012 |
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
|
text
|
January 2014 |
Protein Crystallography in Vaccine Research and Development
|
journal
|
June 2015 |
Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein
|
journal
|
June 2015 |
Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
|
journal
|
June 2009 |
Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
|
journal
|
March 2003 |
Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein
|
journal
|
June 2008 |
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
|
journal
|
March 2011 |
Can we control all-cause meningococcal disease in Europe?
|
journal
|
December 2016 |
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome
|
journal
|
December 2019 |
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
|
journal
|
August 2010 |
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation
|
journal
|
February 2021 |
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
|
journal
|
December 2016 |
Vaccines for the 21st century
|
journal
|
April 2014 |
Features and development of Coot
|
journal
|
March 2010 |
4CMenB vaccine effectiveness: reasons for optimism
|
journal
|
December 2016 |
Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens
|
journal
|
January 2015 |
Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine
|
journal
|
September 2015 |
The Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies
|
journal
|
February 2005 |
Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness
|
journal
|
July 2015 |
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
|
journal
|
September 2020 |
Phaser crystallographic software
|
journal
|
July 2007 |